Research Achievements
Toshinori Nakayama| 2012 | 2011 | 2010 | 2009 | 2008 |
| Papers| International Conferences |
Papers
Ito H‚ Ando K‚ Ishikawa T‚ Nakayama T‚ Taniguchi M‚ Saito K‚ Imawari M‚ Moriwaki H‚ Yokochi T‚ Kakumu S‚ Seishima M. Role of Valpha14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of Valpha14+ NKT cells promotes the breakage of CTL tolerance.
Int Immunol 2008; 20 (7): 869-879
Hayakawa K‚ Tateda K‚ Fuse ET‚ Matsumoto T‚ Akasaka Y‚ Ishii T‚ Nakayama T‚ Taniguchi M‚ Kaku M‚ Standiford TJ‚ Yamaguchi K. Paradoxically high resistance of natural killer T (NKT) cell-deficient mice to Legionella pneumophila: another aspect of NKT cells for modulation of host responses.
J Med Microbiol 2008; 57 (Pt11): 1340-1348
Hossain MB‚ Hosokawa H‚ Hasegawa A‚ Watarai H‚ Taniguchi M‚ Yamashita M‚ Nakayama T. Lymphoid enhancer factor interacts with GATA-3 and controls its function in T helper type 2 cells.
Immunology 2008; 125 (3): 377-386
Terashima A‚ Watarai H‚ Inoue S‚ Sekine E‚ Nakagawa R‚ Hase K‚ Iwamura C‚ Nakajima H‚ Nakayama T‚ Taniguchi M. A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity.
J. Exp. Med. 2008; 205 (12): 2727-2733
Funeshima F N‚ Fujino M‚ Kimura H‚ Takahara S‚ Nakayama T‚ Ezaki T‚ Li X-K. Survival of skin allografts is prolonged in mice with a dominant-negative H-Ras.
Transpl. Immunol. 2008; 18 (4): 302-306
Hoshino A‚ Nagao T‚ Nagi M N‚ Ohno N‚ Yasuhara M‚ Yamamoto K‚ Nakayama T‚ Suzuki K. MPO-ANCA induces Il-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner.
J. Autoimmun. 2008; 31 (1): 79-89
Suto A‚ Kashiwakuma D‚ Kagami S‚ Hirose K‚ Watanabe N‚ Yokote K‚ Saito Y‚ Nakayama T‚ Grusby J. M‚ Iwamoto I‚ Nakajima H. Development and characterization of IL-21-producing CD4+ T cells.
J. Exp. Med. 2008; 205 (6): 1369-1379
Hirahara K‚ Yamashita M‚ Iwamura C‚ Shinoda K‚ Hasegawa A‚ Yoshizawa H‚ Koseki H‚ Gejyo F‚ Nakayama T. Repressor of GATA regulates TH2-driven allergic airway inflammation and airway hyperresponsiveness.
J. Allergy Clin. Immunol. 2008; 122 (3): 512-520.e11
Kawamura T‚ Murakami K‚ Bujo H‚ Unoki H‚ Jiang M‚ Nakayama T‚ Saito Y. Matrix metalloproteinase-3 enhances the free fatty acids-induced VEGF expression in adipocytes through toll-like receptor 2.
Exp. Biol. Med. 2008; 283 (10): 1213-1221
Yamashita M‚ Kuwahara M‚ Suzuki A‚ Hirahara K‚ Shinnakasu R‚ Hosokawa H‚ Hasegawa A‚ Motohashi S‚ Iwama A‚ Nakayama T. Bmi1 regulates memory CD4 T cell sirvival via repression of the Noxa gene.
J. Exp. Med. 2008; 205 (5): 1109-1120
Shinnakasu R‚ Yamashita M‚ Kuwahara M‚ Hosokawa H‚ Hasegawa A‚ Motohashi S‚ Nakayama T. Gfi1-mediated stabilization of GATA3 protein is required for Th2 cell differentiation.
J. Biol. Chem 2008; 283 (42): 28216-28225
Ito T‚ Hasegawa A‚ Hosokawa H‚ Yamashita M‚ Motohashi S‚ Naka T‚ Okamoto Y‚ Fujita Y‚ Ishii Y‚ Taniguchi M‚ Yano I‚ Nakayama T. Human Th1 differentiation induced by lipoarabinomannan / lipomannon from Mycobacterium bovis BCG
International Immunology 2008; 20 849-860
International Conferences
Nakayama T. Regulation of memory Th2 cell survival and function by the Polycomb group and Trithorax group gene products.
Immunochemistry & Immunobiology 2008-8-17 Oxford/UK
Motohashi S‚ Nagato K‚ Fujiwara T‚ Taniguchi M‚ Nakayama T. Phase I/II study of ¦ÁGalCer-pulsed dendritic cell in patients with advanced or recurrent non-small cell lung cancer
2008 American Society of Clinical Oncology Annual Meeting 2008-5-29 Chicago/U.S.A.
Nakayama T. Bmi1 regulates memory Th2 cell survival via repression of the Noxa gene.
Experimental Biology 2008 2008-4-5 San Diego/U.S.A.
Nakayama T. Initiation and maintenance of Th2 cell identity: Regulation by Polycomb and Trithorax group molecules.
Allergy Symposium Program La Jolla Institute for Allergy and Immunology (LIAI)‚ 2008-4-4 San Diego/U.S.A.
Nakayama T. Combination therapy of In vitro expanded natural killer T cells and ¦ÁGalactosylCeramide pulsed APCs in patients with recurrent head and neck carcinoma.
The Second International Cell Therapy Conference Present and Future of Cell Therapy‚ 2008-11-20 Seoul/Korea
